Fresenius Medical Care ( ($FMS) ) has issued an announcement. On October 1, 2025, Fresenius Medical Care announced the appointment of Joseph Turk ...

The Supervisory Board of Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disease, has appointed Joseph E. (Joe) Turk (57) as a member of ...

Care appointed Joseph Turk as a member of the Management Board, effective January 1, 2026. Mr. Turk will serve as CEO of the global operating segment Care Enablement. Turk will succeed Dr. Katarzyna ...

Fresenius Kabi, a part of the global healthcare company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific billing code for ...

Detailed price information for Carlisle Companies Inc (CSL-N) from The Globe and Mail including charting and trades.

Prudential Financial is laying off up to 63 employees in Newark after earlier announcing 63 cuts in July. The firm terminated over 600 in 2024.

FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.

ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung (ForTra), supports the legally compliant production of new pharmaceutical products under GMP conditions that will be directly ...

Fresenius Medical Care said it invested 312 million euros ($367.8 million) to buy out nonphysician investors in its majority-owned Interwell Health kidney-care business, and named a new head for the ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced several important developments in its Value-Based Care (VBC) ...

The global Medical Membrane Market is poised for remarkable growth over the next decade, with the industry estimated at USD 4 ...

Executives from three U.S. health systems gave Newsweek a look at their tech portfolios—and explained the reasoning behind those investments.